| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (4MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-785553
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.78555
Zusammenfassung
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity. Excess cholesterol, the hepatic and circulating levels of which are regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9), exacerbates MASLD. Data on hepatic and circulating PCSK9 protein expression in MASLD are inconsistent, and PCSK9 levels in different adipose tissues have not been ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik